跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REXULTI brexpiprazole 0.5 mg film coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
REXULTI brexpiprazole 0.5 mg film coated tablet blister pack
Approved
STANDARD
REXULTI brexpiprazole 0.5 mg film coated tablet blister pack
Lundbeck Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
4810c0cc92976a4e
Company
Lundbeck Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
4810c0cc92976a4e
Product Name
REXULTI brexpiprazole 0.5 mg film coated tablet blister pack
Artg Id
273222
Artg Name
REXULTI brexpiprazole 0.5 mg film coated tablet blister pack
Sponsor
Lundbeck Australia Pty Ltd
Company Detail Path
/organization/lundbeck-australia-pty-ltd
Artg Date
2017-05-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/de90ab93aac67fb9578282279bcd5ada.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/412fa0b09219d47cf413e279f97ad8ed.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
4810c0cc92976a4e
Type
Standard
Back to TGA Approvals